|
CST3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.661700E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.405700E-02 |
| Normal-vs-Stage2 |
4.088200E-01 |
| Normal-vs-Stage3 |
7.448900E-04 |
| Normal-vs-Stage4 |
6.393900E-02 |
| Stage1-vs-Stage2 |
7.193600E-01 |
| Stage1-vs-Stage3 |
6.108400E-02 |
| Stage1-vs-Stage4 |
6.838000E-01 |
| Stage2-vs-Stage3 |
1.610040E-01 |
| Stage2-vs-Stage4 |
5.558800E-01 |
| Stage3-vs-Stage4 |
3.457600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.037900E-03 |
| Normal-vs-AfricanAmerican |
2.994400E-01 |
| Normal-vs-Asian |
6.325700E-02 |
| Caucasian-vs-AfricanAmerican |
5.032600E-01 |
| Caucasian-vs-Asian |
8.518600E-01 |
| AfricanAmerican-vs-Asian |
5.939000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.338900E-03 |
| Normal-vs-Female |
1.362290E-02 |
| Male-vs-Female |
6.063200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.241700E-02 |
| Normal-vs-Age(41-60Yrs) |
1.260120E-03 |
| Normal-vs-Age(61-80Yrs) |
2.267600E-01 |
| Normal-vs-Age(81-100Yrs) |
3.465600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.258240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.278000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.830800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.474390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.379800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.692000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.478400E-01 |
| Classical-VS-Follicular |
4.615800E-04 |
| Classical-VS-Other |
9.749200E-01 |
| Classical-VS-Normal |
2.119400E-03 |
| Tall-VS-Follicular |
4.636600E-03 |
| Tall-VS-Other |
7.623400E-01 |
| Tall-VS-Normal |
1.504340E-02 |
| Follicular-VS-Other |
1.931400E-01 |
| Follicular-VS-Normal |
5.246400E-01 |
| Other-VS-Normal |
1.670790E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.253900E-02 |
| Normal-vs-N1 |
9.820300E-03 |
| N0-vs-N1 |
3.483000E-01 |
|
|
